NI-0101

anti-TLR4 monoclonal antibody NI-0101 · Novimmune SA / Light Chain Bioscience

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NI-0101, covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers [Phase 1]

See pricing